A novel mouse model of in-stent restenosis

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 359-366

  Rodriguez Menocal, Luis ^a   Wei, Yuntao ^a   Pham, Si M ^a   St Pierre, Melissa ^a   Li, Sen ^a   Webster, Keith ^a   Goldschmidt Clermont, Pascal ^a   Vazquez Padron, Roberto I ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; In stent restenosis; Mouse; Stent

Indexed keywords

APOLIPOPROTEIN E; MATRIX METALLOPROTEINASE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; BARE METAL STENT; C57BL 6 MOUSE; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT PATENCY; HISTOPATHOLOGY; IMPLANTATION; IN-STENT RESTENOSIS; LEUKOCYTE ADHERENCE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STENT THROMBOSIS; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; AORTA, ABDOMINAL; APOLIPOPROTEINS E; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; STENTS; TOMOGRAPHY, OPTICAL; TUNICA INTIMA;

EID: 77950023317     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.071     Document Type: Article

References (33)

1. Lowe H.C., Oesterle S.N., Khachigian L.M. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002, 39:183-193.
2. Geary R.L., Clowes A.W. Epidemiology and pathogenesis of restenosis. Essentials of restenosis 2007, Humana Press, New Jersey. H.D. Duckers, E.G. Nabel, P.W. Serruys (Eds.).
3. Al Suwaidi J., Berger P.B., Holmes D.R. Coronary artery stents. JAMA 2000, 284:1828-1836.
4. Mitra A.K., Agrawal D.K. In stent restenosis: bane of the stent era. J Clin Pathol 2006, 59:232-239.
5. Welt F.G.P., Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769-1776.
6. Gershlick A.H., Baron J. Dealing with in-stent restenosis. Heart 1998, 79:319-323.
7. Deux J.-F., Meddahi-Pelle A., Le Blanche A.F., et al. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler Thromb Vasc Biol 2002, 22:1604-1609.
8. Rogers C., Edelman E.R. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995, 91:2995-3001.
9. Schwartz R.S., Edwards W.D., Bailey K.R., et al. Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models. Arterioscler Thromb 1994, 14:395-400.
10. Lowe H.C., Schwartz R.S., Mac Neill B.D., et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003, 60:515-523.
11. Schwartz R.S., Huber K.C., Murphy J.G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
12. Lowe H.C., James B., Khachigian L.M. A novel model of in-stent restenosis: rat aortic stenting. Heart 2005, 91:393-395.
13. Roks A.J., Henning R.H., van Boven A.J., Tio R.A., van Gilst W.H. Rat abdominal aortic stenting: a simple model displaying in-stent restenosis. Am J Cardiol 2002, 89:1149-1150.
14. Schwartz R.S., Chronos N.A., Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004, 44:1373-1385.
15. Peters L.L., Robledo R.F., Bult C.J., et al. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 2007, 8:58-69.
16. Wouters K., Shiri-Sverdlov R., van Gorp P.J., van Bilsen M., Hofker M.H. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin Chem Lab Med 2005, 43:470-479.
17. Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272:685-688.
18. Fazio S., Linton M.F. Mouse models of hyperlipidemia and atherosclerosis. Front Biosci 2001, 6:D515-525.
19. Ali Z.A., Alp N.J., Lupton H., et al. Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting. Arterioscler Thromb Vasc Biol 2007, 27:833-840.
20. Rippstein P., Black M.K., Boivin M., et al. Comparison of processing and sectioning methodologies for arteries containing metallic stents. J Histochem Cytochem 2006, 54:673-681.
21. Kornowski R., Hong M.K., Tio F.O., et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998, 31:224-230.
22. Ntziachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng 2006, 8:1-33.
23. Chomczynski P., Mackey K. Short technical report. Modification of the TRIZOL reagent procedure for isolation of RNA from Polysaccharide-and proteoglycan-rich sources. Biotechniques 1995, 19:942-945.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT. Methods 2001, 25:402-408.
25. Jones G.T., Kay I.P., Chu J.W.S., et al. Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis. Arterioscler Thromb Vasc Biol 2006, 26:e121-125.
26. Ge J., Shen C., Liang C., et al. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol 2006, 112:85-90.
27. Feldman L.J., Mazighi M., Scheuble A., et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001, 103:3117-3122.
28. MacNeill B.D., Lowe H.C., Takano M., Fuster V., Jang I.-K. Intravascular modalities for detection of vulnerable plaque: current status. Arterioscler Thromb Vasc Biol 2003, 23:1333-1342.
29. Fayad Z.A., Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001, 89:305-316.
30. Escolar E., Weigold G., Fuisz A., Weissman N.J. New imaging techniques for diagnosing coronary artery disease. Can Med Assoc J 2006, 174:487-495.
31. Deguchi J.-O., Aikawa M., Tung C.-H., et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006, 114:55-62.
32. Smith J. Quantitative trait locus mapping for atherosclerosis susceptibility. Curr Opin Lipidol 2003, 14:499-504.
33. Harmon K.J., Couper L.L., Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 2000, 156:1741-1748.